111 related articles for article (PubMed ID: 4085979)
1. Carcinoembryonic antigen expression and peanut agglutinin binding in primary breast cancer and lymph node metastases; lack of correlation with clinical, histopathological, biochemical and morphometric features.
van der Linden JC; Baak JP; Lindeman J; Smeulders AW; Meyer CJ
Histopathology; 1985 Oct; 9(10):1051-9. PubMed ID: 4085979
[TBL] [Abstract][Full Text] [Related]
2. Carcinoembryonic antigen expression & peanut agglutinin binding by breast lesions.
Misra K; Bhatia A
Indian J Med Res; 1987 Oct; 86():485-92. PubMed ID: 3443482
[No Abstract] [Full Text] [Related]
3. Morphometry and breast cancer. II. Characterisation of breast cancer cells with high malignant potential in patients with spread to lymph nodes: preliminary results.
van der Linden HC; Baak JP; Lindeman J; Hermans J; Meyer CJ
J Clin Pathol; 1986 Jun; 39(6):603-9. PubMed ID: 3722413
[TBL] [Abstract][Full Text] [Related]
4. Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma.
Shousha S; Lyssiotis T
Histopathology; 1978 Nov; 2(6):433-47. PubMed ID: 365699
[TBL] [Abstract][Full Text] [Related]
5. Monitoring serum CEA in women with primary breast tumours positive for oestrogen receptor and with spread to lymph nodes.
van der Linden JC; Baak JP; Postma T; Lindeman J; Meyer CJ
J Clin Pathol; 1985 Nov; 38(11):1229-34. PubMed ID: 4066982
[TBL] [Abstract][Full Text] [Related]
6. The lectin-binding sites for peanut agglutinin in invasive breast ductal carcinomas and their role as a prognostic factor.
Mustac E; Melato M; Sasso F; Valkovic T; Bottin C; Jonjic N
J Cancer Res Clin Oncol; 1996; 122(11):693-7. PubMed ID: 8898981
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of lectin receptor and carcinoembryonic antigen in the cancerous and non-cancerous tissues in the human breast].
Zheng Z
Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):353-6. PubMed ID: 1337891
[TBL] [Abstract][Full Text] [Related]
9. [Comparative morphologic and biochemical determinations of CEA and TPA in invasive breast cancers with special reference to lectin histochemistry and hormone receptor status].
Vogel J; Oehr P; Totović V; Bellmann O; Dworak O
Verh Dtsch Ges Pathol; 1985; 69():226-31. PubMed ID: 3913197
[No Abstract] [Full Text] [Related]
10. Carcinoembryonic antigen expression in stages I and II breast cancer: its relationship with clinicopathologic factors.
Sundblad AS; Pellicer EM; Ricci L
Hum Pathol; 1996 Mar; 27(3):297-301. PubMed ID: 8600046
[TBL] [Abstract][Full Text] [Related]
11. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
12. The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications.
Kuhajda FP; Offutt LE; Mendelsohn G
Cancer; 1983 Oct; 52(7):1257-64. PubMed ID: 6192897
[TBL] [Abstract][Full Text] [Related]
13. An observation of DNA ploidy, histological grade, and immunoreactivity for tumour-related antigens in primary and metastatic breast carcinoma.
Hitchcock A; Ellis IO; Robertson JF; Gilmour A; Bell J; Elston CW; Blamey RW
J Pathol; 1989 Oct; 159(2):129-34. PubMed ID: 2553906
[TBL] [Abstract][Full Text] [Related]
14. Tissue carcinoembryonic antigen in the prognosis of early invasive breast cancer.
Hegg R; De Souza AZ; Pestana CB; Cardoso de Almeida PC
Breast Cancer Res Treat; 1990 May; 15(3):213-6. PubMed ID: 2164851
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
Smith SR; Howell A; Minawa A; Morrison JM
Br J Cancer; 1982 Nov; 46(5):757-64. PubMed ID: 6756459
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.
Bhatavdekar JM; Balar DB; Shah NG; Trivedi SN; Bhaduri A; Patel DD; Karelia NH; Shukla MK; Ghosh N
Tumour Biol; 1987; 8(5):233-40. PubMed ID: 3448770
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
18. The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.
Olszewski WP; Szumera-Ciećkiewicz A; Piechocki J; Towpik E; Olszewski WT
Pol J Pathol; 2009; 60(3):138-43. PubMed ID: 20069508
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of carcinoembryonic antigen in human breast carcinomas by the immunoperoxidase technique.
Walker RA
J Clin Pathol; 1980 Apr; 33(4):356-60. PubMed ID: 6995487
[TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen expression and patient survival in carcinoma of the breast.
Halter SA; Fraker LD; Parmenter M; Dupont WD
Oncology; 1984; 41(5):297-302. PubMed ID: 6382094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
